Further, additional data from the laboratory demonstrated that LCN2 could promote tumor progression and therapy resistance in colorectal cancer and promote invasion in colorectal cancer cell lines (Chaudhary et al., 2021; Choudhary et al., 2023). The gene discussed is LCN2; the disease is neoplasm.